|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
2
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complimentary to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim VN, Han J and Siomi MC: Biogenesis of
small RNAs in animals. Nat Rev Mol Cell Biol. 10:126–139. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang ZX, Lu BB, Wang H, Cheng ZX and Yin
YM: MicroRNA-21 modulates chemosensitivity of breast cancer cells
to doxorubicin by targeting PTEN. Arch Med Res. 42:281–290. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Di Leva G and Croce CM: Roles of small
RNAs in tumor formation. Trends Mol Med. 16:257–267.
2010.PubMed/NCBI
|
|
6
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Selcuklu SD, Donoghue MT and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37:918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Faraoni I, Antonetti FR, Cardone J and
Bonmassar E: miR-155 gene: a typical multifunctional microRNA.
Biochim Biophys Acta. 1792:497–505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y and Lee CG: MicroRNA and cancer -
focus on apoptosis. J Cell Mol Med. 13:12–23. 2009. View Article : Google Scholar
|
|
10
|
Yan LX, Huang XF, Shao Q, Huang MY, Deng
L, Wu QL, Zeng YX and Shao JY: MicroRNA miR-21 overexpression in
human breast cancer is associated with advanced clinical stage,
lymph node metastasis and patient poor prognosis. RNA.
14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
et al: MicroRNA gene expression deregulation in human breast
cancer. Cancer Res. 65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lodygin D, Tarasov V, Epanchintsev A,
Berking C, Knyazeva T, Körner H, Knyazev P, Diebold J and Hermeking
H: Inactivation of miR-34a by aberrant CpG methylation in multiple
types of cancer. Cell Cycle. 7:2591–2600. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sempere LF, Christensen M, Silahtaroglu A,
Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S and Cole CN:
Altered MicroRNA expression confined to specific epithelial cell
subpopulations in breast cancer. Cancer Res. 67:11612–11620. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kondo N, Toyama T, Sugiura H, Fujii Y and
Yamashita H: miR-206 expression is down-regulated in estrogen
receptor alpha -positive human breast cancer. Cancer Res.
68:5004–5008. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang Q, Gumireddy K, Schrier M, le Sage
C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, et al:
The microRNAs miR-373 and miR-520c promote tumour invasion and
metastasis. Nat Cell Biol. 10:202–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Valastyan S, Reinhardt F, Benaich N,
Calogrias D, Szász AM, Wang ZC, Brock JE, Richardson AL and
Weinberg RA: A pleiotropically acting microRNA, miR-31, inhibits
breast cancer metastasis. Cell. 137:1032–1046. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu XX, Li XJ, Zhang B, Liang YJ, Zhou CX,
Cao DX, He M, Chen GQ, He JR and Zhao Q: MicroRNA-26b is
underexpressed in human breast cancer and induces cell apoptosis by
targeting SLC7A11. FEBS Lett. 585:1363–1367. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang F, Zheng Z, Guo J and Ding X:
Correlation and quantitation of microRNA aberrant expression in
tissues and serum from patients with breast tumor. Gynecol Oncol.
119:586–593. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Turchinovich A, Weiz L and Burwinkel B:
Extracellular miRNAs: the mystery of their origin and function.
Trends Biochem Sci. 37:460–465. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang JX, Song W, Chen ZH, Wei JH, Liao
YJ, Lei J, Hu M, Chen GZ, Liao B, Lu J, Zhao HW, Chen W, He YL,
Wang HY, Xie D and Luo JH: Prognostic and predictive value of a
microRNA signature in stage II colon cancer: a microRNA expression
analysis. Lancet Oncol. 14:1295–1306. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Frank GA, Danilova NV, Andreeva IuIu and
Nefedova NA: WHO classification of tumors of the breast, 2012. Arkh
Patol. 75:53–63. 2013.(In Russian).
|
|
23
|
Wang H, Peng W, Ouyang X, Li W and Dai Y:
Circulating microRNAs as candidate biomarkers in patients with
systemic lupus erythematosus. Transl Res. 160:198–206. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsui NB, Ng EK and Lo YM: Stability of
endogenous and added RNA in blood specimens, serum, and plasma.
Clin Chem. 48:1647–1653. 2002.PubMed/NCBI
|
|
25
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant
KC, Allen A, et al: Circulating microRNAs as stable blood based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang H, Peng W, Ouyang X, Li W and Dai Y:
miR-451 were upregulated in the patients with SLE and were also
significantly increased in the patients with RA. J Transl Med.
10:552012.PubMed/NCBI
|
|
27
|
Kovalchuk O, Filkowski J, Meservy J,
Ilnytskyy Y, Tryndyak VP, Chekhun VF and Pogribny IP: Involvement
of microRNA-451 in resistance of the MCF-7 breast cancer cells to
chemotherapeutic drug doxorubicin. Mol Cancer Ther. 7:2152–2159.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li S, Yang C, Zhai L, Zhang W, Yu J, Gu F,
Lang R, Fan Y, Gong M, Zhang X and Fu L: Deep sequencing reveals
small RNA characterization of invasive micropapillary carcinomas of
the breast. Breast Cancer Res Treat. 136:77–87. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu Q, Jiang Y, Yin Y, Li Q, He J, Jing Y,
Qi YT, Xu Q, Li W, Lu B, Peiper SS, Jiang BH and Liu LZ: A
regulatory circuit of miR-148a/152 and DNMT1 in modulating cell
transformation and tumor angiogenesis through IGF-IR and IRS1. J
Mol Cell Biol. 5:3–13. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang W, Zhu J, Su S, Wu W, Liu Q, Su F and
Yu F: MiR-27 as a prognostic marker for breast cancer progression
and patient survival. PLoS One. 7:e517022012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Catucci I, Verderio P, Pizzamiglio S,
Bernard L, Dall’olio V, Sardella D, Ravagnani F, Galastri L, Barile
M, Peissel B, et al: The SNP rs895819 in miR-27a is not associated
with familial breast cancer risk in Italians. Breast Cancer Res
Treat. 133:805–807. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Haque R, Chun E, Howell JC, Sengupta T,
Chen D and Kim H: MicroRNA-30b-mediated regulation of catalase
expression in human ARPE-19 cells. PLoS One. 7:e425422012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ichikawa T, Sato F, Terasawa K, Tsuchiya
S, Toi M, Tsujimoto G and Shimizu K: Trastuzumab produces
therapeutic actions by upregulating miR-26a and miR-30b in breast
cancer cells. PLoS One. 7:e314222012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Van der Auwera I, Limame R, van Dam P,
Vermeulen PB, Dirix LY and Van Laere SJ: Integrated miRNA and mRNA
expression profiling of the inflammatory breast cancer subtype. Br
J Cancer. 103:532–541. 2010.PubMed/NCBI
|
|
35
|
Rouas R, Fayyad-Kazan H, El Zein N,
Lewalle P, Rothé F, Simion A, Akl H, Mourtada M, El Rifai M, Burny
A, et al: Human natural Treg microRNA signature: role of
microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol.
39:1608–1618. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chang SJ, Weng SL, Hsieh JY, Wang TY,
Chang MD and Wang HW: MicroRNA-34a modulates genes involved in
cellular motility and oxidative phosphorylation in neural
precursors derived from human umbilical cord mesenchymal stem
cells. BMC Med Genomics. 4:652011. View Article : Google Scholar
|
|
37
|
Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma
ES, Pang R, Chua D, Chu KM, Law WL, Law SY, Poon RT and Kwong A:
Circulating microRNAs as specific biomarkers for breast cancer
detection. PLoS One. 8:e531412013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Iguchi H, Kosaka N and Ochiya T: Secretory
microRNAs as a versatile communication tool. Commun Integr Biol.
3:478–481. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kosaka N, Iguchi H and Ochiya T:
Circulating microRNA in body fluid: a new potential biomarker for
cancer diagnosis and prognosis. Cancer Sci. 101:2087–2092. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Catucci I, Verderio P, Pizzamiglio S,
Bernard L, Dall’olio V, Sardella D, Ravagnani F, Galastri L, Barile
M, Peissel B, Zaffaroni D, Manoukian S, Radice P and Peterlongo P:
The SNP rs895819 in miR-27a is not associated with familial breast
cancer risk in Italians. Breast Cancer Res Treat. 133:805–807.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hezova R, Kovarikova A, Bienertova-Vasku
J, Sachlova M, Redova M, Vasku A, Svoboda M, Radova L, Kiss I,
Vyzula R and Slaby O: Evaluation of SNPs in miR-196-a2, miR-27a and
miR-146a as risk factors of colorectal cancer. World J
Gastroenterol. 18:2827–2831. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Katada T, Ishiguro H, Kuwabara Y, Kimura
M, Mitui A, Mori Y, Ogawa R, Harata K and Fujii Y: microRNA
expression profile in undifferentiated gastric cancer. Int J Oncol.
34:537–542. 2009.PubMed/NCBI
|
|
43
|
Redova M, Poprach A, Nekvindova J, Iliev
R, Radova L, Lakomy R, Svoboda M, Vyzula R and Slaby O: Circulating
miR-378 and miR-451 in serum are potential biomarkers for renal
cell carcinoma. J Transl Med. 10:552012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zheng B, Liang L, Wang C, Huang S, Cao X,
Zha R, Liu L, Jia D, Tian Q, Wu J, et al: MicroRNA-148a suppresses
tumor cell invasion and metastasis by downregulating ROCK1 in
gastric cancer. Clin Cancer Res. 17:7574–7583. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wszolek MF, Rieger-Christ KM, Kenney PA,
Gould JJ, Silva Neto B, Lavoie AK, Logvinenko T, Libertino JA and
Summerhayes IC: A MicroRNA expression profile defining the invasive
bladder tumor phenotype. Urol Oncol. 29:794–801. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Gao W, Shen H, Liu L, Xu J, Xu J and Shu
Y: MiR-21 overexpression in human primary squamous cell lung
carcinoma is associated with poor patient prognosis. J Cancer Res
Clin Oncol. 137:557–566. 2011. View Article : Google Scholar : PubMed/NCBI
|
